THY1 and synucleinopathy: Follow-up investigations should be conducted in established synucleinopathy in vivo models, such as Thy1-SNCA transgenic mice, to rigorously assess the effects of rHsCTSB and rHsCTSL on disease-relevant phenotypes and behavioral outcomes.